nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—ALB—Crohn's disease	0.5	1	CbGaD
Clomipramine—ALB—Prednisone—Crohn's disease	0.0241	0.402	CbGbCtD
Clomipramine—CYP2C19—Prednisone—Crohn's disease	0.0156	0.261	CbGbCtD
Clomipramine—HTR2A—enteric nervous system—Crohn's disease	0.0132	0.178	CbGeAlD
Clomipramine—ABCB1—Prednisone—Crohn's disease	0.0126	0.21	CbGbCtD
Clomipramine—HTR2A—myenteric nerve plexus—Crohn's disease	0.00997	0.135	CbGeAlD
Clomipramine—CYP3A4—Prednisone—Crohn's disease	0.00755	0.126	CbGbCtD
Clomipramine—GSTP1—gall bladder—Crohn's disease	0.00436	0.059	CbGeAlD
Clomipramine—GSTP1—mouth—Crohn's disease	0.00387	0.0525	CbGeAlD
Clomipramine—ALB—gall bladder—Crohn's disease	0.00373	0.0506	CbGeAlD
Clomipramine—HRH2—skin of body—Crohn's disease	0.00298	0.0403	CbGeAlD
Clomipramine—HRH2—digestive system—Crohn's disease	0.00238	0.0323	CbGeAlD
Clomipramine—GSTP1—epithelium—Crohn's disease	0.00225	0.0305	CbGeAlD
Clomipramine—GSTP1—smooth muscle tissue—Crohn's disease	0.00217	0.0294	CbGeAlD
Clomipramine—GSTP1—skin of body—Crohn's disease	0.00214	0.0291	CbGeAlD
Clomipramine—GSTP1—mammalian vulva—Crohn's disease	0.00195	0.0265	CbGeAlD
Clomipramine—HTR2B—smooth muscle tissue—Crohn's disease	0.00179	0.0243	CbGeAlD
Clomipramine—HTR2B—skin of body—Crohn's disease	0.00177	0.024	CbGeAlD
Clomipramine—GSTP1—lymphoid tissue—Crohn's disease	0.00174	0.0235	CbGeAlD
Clomipramine—GSTP1—digestive system—Crohn's disease	0.00171	0.0232	CbGeAlD
Clomipramine—SLC6A4—digestive system—Crohn's disease	0.00143	0.0193	CbGeAlD
Clomipramine—HTR2B—digestive system—Crohn's disease	0.00141	0.0192	CbGeAlD
Clomipramine—HRH2—lymph node—Crohn's disease	0.00136	0.0184	CbGeAlD
Clomipramine—CYP2C19—digestive system—Crohn's disease	0.00118	0.016	CbGeAlD
Clomipramine—ADRA2A—mammalian vulva—Crohn's disease	0.00101	0.0137	CbGeAlD
Clomipramine—HTR2A—epithelium—Crohn's disease	0.000992	0.0135	CbGeAlD
Clomipramine—GSTP1—lymph node—Crohn's disease	0.000979	0.0133	CbGeAlD
Clomipramine—CYP1A2—digestive system—Crohn's disease	0.000965	0.0131	CbGeAlD
Clomipramine—HTR2A—smooth muscle tissue—Crohn's disease	0.000956	0.013	CbGeAlD
Clomipramine—ALB—lymph node—Crohn's disease	0.000838	0.0114	CbGeAlD
Clomipramine—Mood swings—Mesalazine—Crohn's disease	0.000825	0.00284	CcSEcCtD
Clomipramine—Arthralgia—Mercaptopurine—Crohn's disease	0.000823	0.00283	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.000817	0.00281	CcSEcCtD
Clomipramine—Memory impairment—Prednisone—Crohn's disease	0.000809	0.00278	CcSEcCtD
Clomipramine—HTR2B—lymph node—Crohn's disease	0.000807	0.0109	CbGeAlD
Clomipramine—Dry skin—Mesalazine—Crohn's disease	0.000798	0.00275	CcSEcCtD
Clomipramine—Orthostatic hypotension—Mesalazine—Crohn's disease	0.000795	0.00274	CcSEcCtD
Clomipramine—Oedema—Mercaptopurine—Crohn's disease	0.000789	0.00271	CcSEcCtD
Clomipramine—Breast disorder—Mesalazine—Crohn's disease	0.000787	0.00271	CcSEcCtD
Clomipramine—Pancytopenia—Azathioprine—Crohn's disease	0.000785	0.0027	CcSEcCtD
Clomipramine—Glycosuria—Prednisone—Crohn's disease	0.000783	0.0027	CcSEcCtD
Clomipramine—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000772	0.00266	CcSEcCtD
Clomipramine—Gastritis—Mesalazine—Crohn's disease	0.000771	0.00265	CcSEcCtD
Clomipramine—Skin disorder—Mercaptopurine—Crohn's disease	0.000766	0.00264	CcSEcCtD
Clomipramine—Endocrine disorder—Prednisone—Crohn's disease	0.000766	0.00263	CcSEcCtD
Clomipramine—HTR2A—digestive system—Crohn's disease	0.000755	0.0102	CbGeAlD
Clomipramine—Acne—Prednisone—Crohn's disease	0.000754	0.0026	CcSEcCtD
Clomipramine—Dysphagia—Mesalazine—Crohn's disease	0.000753	0.00259	CcSEcCtD
Clomipramine—Anorexia—Mercaptopurine—Crohn's disease	0.000752	0.00259	CcSEcCtD
Clomipramine—Eosinophilia—Mesalazine—Crohn's disease	0.000745	0.00256	CcSEcCtD
Clomipramine—Pneumonia—Azathioprine—Crohn's disease	0.000741	0.00255	CcSEcCtD
Clomipramine—Bronchospasm—Mesalazine—Crohn's disease	0.00074	0.00255	CcSEcCtD
Clomipramine—Delirium—Prednisone—Crohn's disease	0.000738	0.00254	CcSEcCtD
Clomipramine—Desipramine—SLC22A4—Crohn's disease	0.000731	0.227	CrCbGaD
Clomipramine—Contusion—Prednisone—Crohn's disease	0.000728	0.0025	CcSEcCtD
Clomipramine—Bronchitis—Mesalazine—Crohn's disease	0.000724	0.00249	CcSEcCtD
Clomipramine—Amenorrhoea—Prednisone—Crohn's disease	0.000722	0.00249	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000719	0.00247	CcSEcCtD
Clomipramine—SLC6A2—lymph node—Crohn's disease	0.000717	0.00972	CbGeAlD
Clomipramine—Pancytopenia—Mesalazine—Crohn's disease	0.000715	0.00246	CcSEcCtD
Clomipramine—Dysuria—Mesalazine—Crohn's disease	0.000704	0.00242	CcSEcCtD
Clomipramine—CYP3A4—digestive system—Crohn's disease	0.000699	0.00947	CbGeAlD
Clomipramine—Arthropathy—Prednisone—Crohn's disease	0.000698	0.0024	CcSEcCtD
Clomipramine—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000697	0.0024	CcSEcCtD
Clomipramine—Pollakiuria—Mesalazine—Crohn's disease	0.000695	0.00239	CcSEcCtD
Clomipramine—CYP2D6—digestive system—Crohn's disease	0.000688	0.00932	CbGeAlD
Clomipramine—Agranulocytosis—Azathioprine—Crohn's disease	0.000688	0.00237	CcSEcCtD
Clomipramine—Photosensitivity reaction—Mesalazine—Crohn's disease	0.000687	0.00236	CcSEcCtD
Clomipramine—Decreased appetite—Mercaptopurine—Crohn's disease	0.000686	0.00236	CcSEcCtD
Clomipramine—Weight increased—Mesalazine—Crohn's disease	0.000685	0.00236	CcSEcCtD
Clomipramine—Weight decreased—Mesalazine—Crohn's disease	0.000681	0.00234	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000681	0.00234	CcSEcCtD
Clomipramine—Pneumonia—Mesalazine—Crohn's disease	0.000675	0.00232	CcSEcCtD
Clomipramine—Hypercholesterolaemia—Prednisone—Crohn's disease	0.000671	0.00231	CcSEcCtD
Clomipramine—Depression—Mesalazine—Crohn's disease	0.000669	0.0023	CcSEcCtD
Clomipramine—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000658	0.00226	CcSEcCtD
Clomipramine—Jaundice—Mesalazine—Crohn's disease	0.000654	0.00225	CcSEcCtD
Clomipramine—Conjunctivitis—Mesalazine—Crohn's disease	0.000652	0.00224	CcSEcCtD
Clomipramine—Urinary tract infection—Mesalazine—Crohn's disease	0.000652	0.00224	CcSEcCtD
Clomipramine—ABCB1—epithelium—Crohn's disease	0.00065	0.00881	CbGeAlD
Clomipramine—Sweating—Mesalazine—Crohn's disease	0.000643	0.00221	CcSEcCtD
Clomipramine—Haematuria—Mesalazine—Crohn's disease	0.00064	0.0022	CcSEcCtD
Clomipramine—Hiccups—Prednisone—Crohn's disease	0.000635	0.00218	CcSEcCtD
Clomipramine—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000635	0.00218	CcSEcCtD
Clomipramine—Epistaxis—Mesalazine—Crohn's disease	0.000633	0.00218	CcSEcCtD
Clomipramine—Sinusitis—Mesalazine—Crohn's disease	0.00063	0.00217	CcSEcCtD
Clomipramine—Agranulocytosis—Mesalazine—Crohn's disease	0.000626	0.00215	CcSEcCtD
Clomipramine—Body temperature increased—Mercaptopurine—Crohn's disease	0.000623	0.00214	CcSEcCtD
Clomipramine—Imipramine—SLC22A4—Crohn's disease	0.00062	0.193	CrCbGaD
Clomipramine—Rhinitis—Mesalazine—Crohn's disease	0.000604	0.00208	CcSEcCtD
Clomipramine—Hepatitis—Mesalazine—Crohn's disease	0.000602	0.00207	CcSEcCtD
Clomipramine—Pharyngitis—Mesalazine—Crohn's disease	0.000598	0.00206	CcSEcCtD
Clomipramine—Immune system disorder—Azathioprine—Crohn's disease	0.000597	0.00206	CcSEcCtD
Clomipramine—Mediastinal disorder—Azathioprine—Crohn's disease	0.000596	0.00205	CcSEcCtD
Clomipramine—Neuropathy—Prednisone—Crohn's disease	0.000596	0.00205	CcSEcCtD
Clomipramine—Urinary tract disorder—Mesalazine—Crohn's disease	0.000595	0.00205	CcSEcCtD
Clomipramine—Chills—Azathioprine—Crohn's disease	0.000593	0.00204	CcSEcCtD
Clomipramine—Connective tissue disorder—Mesalazine—Crohn's disease	0.000592	0.00204	CcSEcCtD
Clomipramine—Arrhythmia—Azathioprine—Crohn's disease	0.000591	0.00203	CcSEcCtD
Clomipramine—Urethral disorder—Mesalazine—Crohn's disease	0.000591	0.00203	CcSEcCtD
Clomipramine—Alopecia—Azathioprine—Crohn's disease	0.000584	0.00201	CcSEcCtD
Clomipramine—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000581	0.002	CcSEcCtD
Clomipramine—Oesophagitis—Prednisone—Crohn's disease	0.00058	0.002	CcSEcCtD
Clomipramine—ABCB1—mammalian vulva—Crohn's disease	0.000564	0.00765	CbGeAlD
Clomipramine—Eye disorder—Mesalazine—Crohn's disease	0.000563	0.00194	CcSEcCtD
Clomipramine—Tinnitus—Mesalazine—Crohn's disease	0.000562	0.00193	CcSEcCtD
Clomipramine—Cardiac disorder—Mesalazine—Crohn's disease	0.000559	0.00192	CcSEcCtD
Clomipramine—Hyperkinesia—Prednisone—Crohn's disease	0.000554	0.0019	CcSEcCtD
Clomipramine—Desipramine—SLC22A5—Crohn's disease	0.00055	0.171	CrCbGaD
Clomipramine—Angiopathy—Mesalazine—Crohn's disease	0.000547	0.00188	CcSEcCtD
Clomipramine—Euphoric mood—Prednisone—Crohn's disease	0.000545	0.00188	CcSEcCtD
Clomipramine—Immune system disorder—Mesalazine—Crohn's disease	0.000544	0.00187	CcSEcCtD
Clomipramine—Mediastinal disorder—Mesalazine—Crohn's disease	0.000543	0.00187	CcSEcCtD
Clomipramine—Chills—Mesalazine—Crohn's disease	0.000541	0.00186	CcSEcCtD
Clomipramine—Diarrhoea—Mercaptopurine—Crohn's disease	0.00054	0.00186	CcSEcCtD
Clomipramine—Ill-defined disorder—Azathioprine—Crohn's disease	0.000534	0.00184	CcSEcCtD
Clomipramine—Alopecia—Mesalazine—Crohn's disease	0.000532	0.00183	CcSEcCtD
Clomipramine—Thrombophlebitis—Prednisone—Crohn's disease	0.000532	0.00183	CcSEcCtD
Clomipramine—Anaemia—Azathioprine—Crohn's disease	0.000532	0.00183	CcSEcCtD
Clomipramine—Diabetes mellitus—Prednisone—Crohn's disease	0.00053	0.00182	CcSEcCtD
Clomipramine—Mental disorder—Mesalazine—Crohn's disease	0.000528	0.00182	CcSEcCtD
Clomipramine—Malaise—Azathioprine—Crohn's disease	0.000519	0.00179	CcSEcCtD
Clomipramine—Flatulence—Mesalazine—Crohn's disease	0.000517	0.00178	CcSEcCtD
Clomipramine—Leukopenia—Azathioprine—Crohn's disease	0.000515	0.00177	CcSEcCtD
Clomipramine—Vascular purpura—Prednisone—Crohn's disease	0.000515	0.00177	CcSEcCtD
Clomipramine—Tension—Mesalazine—Crohn's disease	0.000515	0.00177	CcSEcCtD
Clomipramine—Dysgeusia—Mesalazine—Crohn's disease	0.000514	0.00177	CcSEcCtD
Clomipramine—Nervousness—Mesalazine—Crohn's disease	0.000509	0.00175	CcSEcCtD
Clomipramine—Cardiac failure congestive—Prednisone—Crohn's disease	0.000508	0.00175	CcSEcCtD
Clomipramine—Back pain—Mesalazine—Crohn's disease	0.000507	0.00175	CcSEcCtD
Clomipramine—ADRA2A—lymph node—Crohn's disease	0.000507	0.00687	CbGeAlD
Clomipramine—Muscle spasms—Mesalazine—Crohn's disease	0.000504	0.00173	CcSEcCtD
Clomipramine—Vomiting—Mercaptopurine—Crohn's disease	0.000501	0.00173	CcSEcCtD
Clomipramine—ABCB1—lymphoid tissue—Crohn's disease	0.000501	0.00679	CbGeAlD
Clomipramine—Rash—Mercaptopurine—Crohn's disease	0.000497	0.00171	CcSEcCtD
Clomipramine—Dermatitis—Mercaptopurine—Crohn's disease	0.000497	0.00171	CcSEcCtD
Clomipramine—ABCB1—digestive system—Crohn's disease	0.000495	0.00671	CbGeAlD
Clomipramine—Vision blurred—Mesalazine—Crohn's disease	0.000494	0.0017	CcSEcCtD
Clomipramine—Tremor—Mesalazine—Crohn's disease	0.000491	0.00169	CcSEcCtD
Clomipramine—Increased appetite—Prednisone—Crohn's disease	0.00049	0.00169	CcSEcCtD
Clomipramine—Arthralgia—Azathioprine—Crohn's disease	0.00049	0.00169	CcSEcCtD
Clomipramine—Myalgia—Azathioprine—Crohn's disease	0.00049	0.00169	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000487	0.00167	CcSEcCtD
Clomipramine—Ill-defined disorder—Mesalazine—Crohn's disease	0.000487	0.00167	CcSEcCtD
Clomipramine—Anaemia—Mesalazine—Crohn's disease	0.000485	0.00167	CcSEcCtD
Clomipramine—Discomfort—Azathioprine—Crohn's disease	0.000484	0.00167	CcSEcCtD
Clomipramine—Purpura—Prednisone—Crohn's disease	0.000478	0.00164	CcSEcCtD
Clomipramine—Malaise—Mesalazine—Crohn's disease	0.000473	0.00163	CcSEcCtD
Clomipramine—Cardiac failure—Prednisone—Crohn's disease	0.000472	0.00162	CcSEcCtD
Clomipramine—Vertigo—Mesalazine—Crohn's disease	0.000471	0.00162	CcSEcCtD
Clomipramine—Syncope—Mesalazine—Crohn's disease	0.00047	0.00162	CcSEcCtD
Clomipramine—Leukopenia—Mesalazine—Crohn's disease	0.000469	0.00162	CcSEcCtD
Clomipramine—Nausea—Mercaptopurine—Crohn's disease	0.000468	0.00161	CcSEcCtD
Clomipramine—Palpitations—Mesalazine—Crohn's disease	0.000463	0.00159	CcSEcCtD
Clomipramine—Loss of consciousness—Mesalazine—Crohn's disease	0.000461	0.00159	CcSEcCtD
Clomipramine—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.000461	0.00159	CcSEcCtD
Clomipramine—Osteoarthritis—Prednisone—Crohn's disease	0.000461	0.00159	CcSEcCtD
Clomipramine—Thrombocytopenia—Azathioprine—Crohn's disease	0.00046	0.00158	CcSEcCtD
Clomipramine—Cough—Mesalazine—Crohn's disease	0.000458	0.00157	CcSEcCtD
Clomipramine—Skin disorder—Azathioprine—Crohn's disease	0.000456	0.00157	CcSEcCtD
Clomipramine—Affect lability—Prednisone—Crohn's disease	0.000454	0.00156	CcSEcCtD
Clomipramine—Hypertension—Mesalazine—Crohn's disease	0.000453	0.00156	CcSEcCtD
Clomipramine—Psychotic disorder—Prednisone—Crohn's disease	0.00045	0.00155	CcSEcCtD
Clomipramine—Arthralgia—Mesalazine—Crohn's disease	0.000446	0.00154	CcSEcCtD
Clomipramine—Chest pain—Mesalazine—Crohn's disease	0.000446	0.00154	CcSEcCtD
Clomipramine—Myalgia—Mesalazine—Crohn's disease	0.000446	0.00154	CcSEcCtD
Clomipramine—Anxiety—Mesalazine—Crohn's disease	0.000445	0.00153	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000443	0.00153	CcSEcCtD
Clomipramine—Discomfort—Mesalazine—Crohn's disease	0.000441	0.00152	CcSEcCtD
Clomipramine—Irritability—Prednisone—Crohn's disease	0.00044	0.00151	CcSEcCtD
Clomipramine—Hypotension—Azathioprine—Crohn's disease	0.000439	0.00151	CcSEcCtD
Clomipramine—Cardiac arrest—Prednisone—Crohn's disease	0.000438	0.00151	CcSEcCtD
Clomipramine—Dry mouth—Mesalazine—Crohn's disease	0.000437	0.0015	CcSEcCtD
Clomipramine—Mood swings—Prednisone—Crohn's disease	0.000436	0.0015	CcSEcCtD
Clomipramine—Confusional state—Mesalazine—Crohn's disease	0.000432	0.00148	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000428	0.00147	CcSEcCtD
Clomipramine—Oedema—Mesalazine—Crohn's disease	0.000428	0.00147	CcSEcCtD
Clomipramine—Anaphylactic shock—Mesalazine—Crohn's disease	0.000428	0.00147	CcSEcCtD
Clomipramine—Dry skin—Prednisone—Crohn's disease	0.000422	0.00145	CcSEcCtD
Clomipramine—Shock—Mesalazine—Crohn's disease	0.000421	0.00145	CcSEcCtD
Clomipramine—Nervous system disorder—Mesalazine—Crohn's disease	0.00042	0.00144	CcSEcCtD
Clomipramine—Hypokalaemia—Prednisone—Crohn's disease	0.000419	0.00144	CcSEcCtD
Clomipramine—Thrombocytopenia—Mesalazine—Crohn's disease	0.000419	0.00144	CcSEcCtD
Clomipramine—Tachycardia—Mesalazine—Crohn's disease	0.000418	0.00144	CcSEcCtD
Clomipramine—Skin disorder—Mesalazine—Crohn's disease	0.000416	0.00143	CcSEcCtD
Clomipramine—Hyperhidrosis—Mesalazine—Crohn's disease	0.000414	0.00142	CcSEcCtD
Clomipramine—Anorexia—Mesalazine—Crohn's disease	0.000408	0.0014	CcSEcCtD
Clomipramine—Muscular weakness—Prednisone—Crohn's disease	0.000406	0.0014	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000406	0.0014	CcSEcCtD
Clomipramine—Hypotension—Mesalazine—Crohn's disease	0.0004	0.00138	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00039	0.00134	CcSEcCtD
Clomipramine—Sweating increased—Prednisone—Crohn's disease	0.000388	0.00133	CcSEcCtD
Clomipramine—Feeling abnormal—Azathioprine—Crohn's disease	0.000387	0.00133	CcSEcCtD
Clomipramine—Insomnia—Mesalazine—Crohn's disease	0.000387	0.00133	CcSEcCtD
Clomipramine—Paraesthesia—Mesalazine—Crohn's disease	0.000384	0.00132	CcSEcCtD
Clomipramine—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000384	0.00132	CcSEcCtD
Clomipramine—Dyspnoea—Mesalazine—Crohn's disease	0.000382	0.00131	CcSEcCtD
Clomipramine—Somnolence—Mesalazine—Crohn's disease	0.000381	0.00131	CcSEcCtD
Clomipramine—Dyspepsia—Mesalazine—Crohn's disease	0.000377	0.0013	CcSEcCtD
Clomipramine—Decreased appetite—Mesalazine—Crohn's disease	0.000372	0.00128	CcSEcCtD
Clomipramine—Abdominal pain—Azathioprine—Crohn's disease	0.000371	0.00128	CcSEcCtD
Clomipramine—Body temperature increased—Azathioprine—Crohn's disease	0.000371	0.00128	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00037	0.00127	CcSEcCtD
Clomipramine—Fatigue—Mesalazine—Crohn's disease	0.000369	0.00127	CcSEcCtD
Clomipramine—Erectile dysfunction—Prednisone—Crohn's disease	0.000367	0.00126	CcSEcCtD
Clomipramine—Pain—Mesalazine—Crohn's disease	0.000366	0.00126	CcSEcCtD
Clomipramine—Constipation—Mesalazine—Crohn's disease	0.000366	0.00126	CcSEcCtD
Clomipramine—Weight increased—Prednisone—Crohn's disease	0.000362	0.00125	CcSEcCtD
Clomipramine—Weight decreased—Prednisone—Crohn's disease	0.00036	0.00124	CcSEcCtD
Clomipramine—Hyperglycaemia—Prednisone—Crohn's disease	0.000359	0.00124	CcSEcCtD
Clomipramine—Depression—Prednisone—Crohn's disease	0.000354	0.00122	CcSEcCtD
Clomipramine—Feeling abnormal—Mesalazine—Crohn's disease	0.000353	0.00121	CcSEcCtD
Clomipramine—Acute coronary syndrome—Prednisone—Crohn's disease	0.00035	0.0012	CcSEcCtD
Clomipramine—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00035	0.0012	CcSEcCtD
Clomipramine—Neuropathy peripheral—Prednisone—Crohn's disease	0.000348	0.0012	CcSEcCtD
Clomipramine—Myocardial infarction—Prednisone—Crohn's disease	0.000348	0.0012	CcSEcCtD
Clomipramine—Hypersensitivity—Azathioprine—Crohn's disease	0.000346	0.00119	CcSEcCtD
Clomipramine—Urticaria—Mesalazine—Crohn's disease	0.00034	0.00117	CcSEcCtD
Clomipramine—Abdominal pain—Mesalazine—Crohn's disease	0.000338	0.00116	CcSEcCtD
Clomipramine—Body temperature increased—Mesalazine—Crohn's disease	0.000338	0.00116	CcSEcCtD
Clomipramine—Bradycardia—Prednisone—Crohn's disease	0.000324	0.00112	CcSEcCtD
Clomipramine—Diarrhoea—Azathioprine—Crohn's disease	0.000322	0.00111	CcSEcCtD
Clomipramine—Hallucination—Prednisone—Crohn's disease	0.000317	0.00109	CcSEcCtD
Clomipramine—Hypersensitivity—Mesalazine—Crohn's disease	0.000315	0.00108	CcSEcCtD
Clomipramine—Connective tissue disorder—Prednisone—Crohn's disease	0.000313	0.00108	CcSEcCtD
Clomipramine—Dizziness—Azathioprine—Crohn's disease	0.000311	0.00107	CcSEcCtD
Clomipramine—Asthenia—Mesalazine—Crohn's disease	0.000307	0.00106	CcSEcCtD
Clomipramine—Pruritus—Mesalazine—Crohn's disease	0.000303	0.00104	CcSEcCtD
Clomipramine—Vomiting—Azathioprine—Crohn's disease	0.000299	0.00103	CcSEcCtD
Clomipramine—Eye disorder—Prednisone—Crohn's disease	0.000298	0.00102	CcSEcCtD
Clomipramine—Rash—Azathioprine—Crohn's disease	0.000296	0.00102	CcSEcCtD
Clomipramine—Dermatitis—Azathioprine—Crohn's disease	0.000296	0.00102	CcSEcCtD
Clomipramine—Flushing—Prednisone—Crohn's disease	0.000296	0.00102	CcSEcCtD
Clomipramine—Headache—Azathioprine—Crohn's disease	0.000294	0.00101	CcSEcCtD
Clomipramine—Diarrhoea—Mesalazine—Crohn's disease	0.000293	0.00101	CcSEcCtD
Clomipramine—Angiopathy—Prednisone—Crohn's disease	0.000289	0.000995	CcSEcCtD
Clomipramine—Immune system disorder—Prednisone—Crohn's disease	0.000288	0.000991	CcSEcCtD
Clomipramine—Arrhythmia—Prednisone—Crohn's disease	0.000285	0.00098	CcSEcCtD
Clomipramine—Dizziness—Mesalazine—Crohn's disease	0.000283	0.000974	CcSEcCtD
Clomipramine—ABCB1—lymph node—Crohn's disease	0.000283	0.00383	CbGeAlD
Clomipramine—Alopecia—Prednisone—Crohn's disease	0.000282	0.000969	CcSEcCtD
Clomipramine—Mental disorder—Prednisone—Crohn's disease	0.000279	0.000961	CcSEcCtD
Clomipramine—Nausea—Azathioprine—Crohn's disease	0.000279	0.00096	CcSEcCtD
Clomipramine—Malnutrition—Prednisone—Crohn's disease	0.000277	0.000955	CcSEcCtD
Clomipramine—Vomiting—Mesalazine—Crohn's disease	0.000272	0.000936	CcSEcCtD
Clomipramine—Rash—Mesalazine—Crohn's disease	0.00027	0.000928	CcSEcCtD
Clomipramine—Dermatitis—Mesalazine—Crohn's disease	0.00027	0.000928	CcSEcCtD
Clomipramine—Headache—Mesalazine—Crohn's disease	0.000268	0.000922	CcSEcCtD
Clomipramine—Vision blurred—Prednisone—Crohn's disease	0.000262	0.0009	CcSEcCtD
Clomipramine—Ill-defined disorder—Prednisone—Crohn's disease	0.000257	0.000886	CcSEcCtD
Clomipramine—Anaemia—Prednisone—Crohn's disease	0.000256	0.000882	CcSEcCtD
Clomipramine—Agitation—Prednisone—Crohn's disease	0.000255	0.000877	CcSEcCtD
Clomipramine—Nausea—Mesalazine—Crohn's disease	0.000254	0.000875	CcSEcCtD
Clomipramine—Malaise—Prednisone—Crohn's disease	0.00025	0.000861	CcSEcCtD
Clomipramine—Vertigo—Prednisone—Crohn's disease	0.000249	0.000858	CcSEcCtD
Clomipramine—Acepromazine—ALB—Crohn's disease	0.000249	0.0775	CrCbGaD
Clomipramine—Syncope—Prednisone—Crohn's disease	0.000249	0.000856	CcSEcCtD
Clomipramine—Loss of consciousness—Prednisone—Crohn's disease	0.000244	0.000839	CcSEcCtD
Clomipramine—Thioproperazine—ALB—Crohn's disease	0.000244	0.0757	CrCbGaD
Clomipramine—Convulsion—Prednisone—Crohn's disease	0.00024	0.000827	CcSEcCtD
Clomipramine—Pipotiazine—ALB—Crohn's disease	0.00024	0.0745	CrCbGaD
Clomipramine—Hypertension—Prednisone—Crohn's disease	0.00024	0.000824	CcSEcCtD
Clomipramine—Arthralgia—Prednisone—Crohn's disease	0.000236	0.000813	CcSEcCtD
Clomipramine—Myalgia—Prednisone—Crohn's disease	0.000236	0.000813	CcSEcCtD
Clomipramine—Anxiety—Prednisone—Crohn's disease	0.000235	0.00081	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000235	0.000807	CcSEcCtD
Clomipramine—Discomfort—Prednisone—Crohn's disease	0.000233	0.000803	CcSEcCtD
Clomipramine—Anaphylactic shock—Prednisone—Crohn's disease	0.000226	0.000779	CcSEcCtD
Clomipramine—Oedema—Prednisone—Crohn's disease	0.000226	0.000779	CcSEcCtD
Clomipramine—Shock—Prednisone—Crohn's disease	0.000223	0.000767	CcSEcCtD
Clomipramine—Nervous system disorder—Prednisone—Crohn's disease	0.000222	0.000764	CcSEcCtD
Clomipramine—Tachycardia—Prednisone—Crohn's disease	0.000221	0.00076	CcSEcCtD
Clomipramine—Skin disorder—Prednisone—Crohn's disease	0.00022	0.000757	CcSEcCtD
Clomipramine—Hyperhidrosis—Prednisone—Crohn's disease	0.000219	0.000753	CcSEcCtD
Clomipramine—Anorexia—Prednisone—Crohn's disease	0.000216	0.000743	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000206	0.00071	CcSEcCtD
Clomipramine—Insomnia—Prednisone—Crohn's disease	0.000205	0.000705	CcSEcCtD
Clomipramine—Paraesthesia—Prednisone—Crohn's disease	0.000203	0.0007	CcSEcCtD
Clomipramine—Dyspepsia—Prednisone—Crohn's disease	0.000199	0.000686	CcSEcCtD
Clomipramine—Decreased appetite—Prednisone—Crohn's disease	0.000197	0.000677	CcSEcCtD
Clomipramine—Fatigue—Prednisone—Crohn's disease	0.000195	0.000672	CcSEcCtD
Clomipramine—Constipation—Prednisone—Crohn's disease	0.000194	0.000666	CcSEcCtD
Clomipramine—Feeling abnormal—Prednisone—Crohn's disease	0.000187	0.000642	CcSEcCtD
Clomipramine—Gastrointestinal pain—Prednisone—Crohn's disease	0.000185	0.000637	CcSEcCtD
Clomipramine—Nortriptyline—ALB—Crohn's disease	0.000185	0.0575	CrCbGaD
Clomipramine—Urticaria—Prednisone—Crohn's disease	0.00018	0.000619	CcSEcCtD
Clomipramine—Abdominal pain—Prednisone—Crohn's disease	0.000179	0.000616	CcSEcCtD
Clomipramine—Body temperature increased—Prednisone—Crohn's disease	0.000179	0.000616	CcSEcCtD
Clomipramine—Hypersensitivity—Prednisone—Crohn's disease	0.000167	0.000574	CcSEcCtD
Clomipramine—Asthenia—Prednisone—Crohn's disease	0.000162	0.000559	CcSEcCtD
Clomipramine—Pruritus—Prednisone—Crohn's disease	0.00016	0.000551	CcSEcCtD
Clomipramine—Diarrhoea—Prednisone—Crohn's disease	0.000155	0.000533	CcSEcCtD
Clomipramine—Dizziness—Prednisone—Crohn's disease	0.00015	0.000515	CcSEcCtD
Clomipramine—Vomiting—Prednisone—Crohn's disease	0.000144	0.000495	CcSEcCtD
Clomipramine—Rash—Prednisone—Crohn's disease	0.000143	0.000491	CcSEcCtD
Clomipramine—Dermatitis—Prednisone—Crohn's disease	0.000143	0.000491	CcSEcCtD
Clomipramine—Headache—Prednisone—Crohn's disease	0.000142	0.000488	CcSEcCtD
Clomipramine—Diazepam—ALB—Crohn's disease	0.00014	0.0435	CrCbGaD
Clomipramine—Nausea—Prednisone—Crohn's disease	0.000135	0.000463	CcSEcCtD
Clomipramine—Chlorpromazine—ALB—Crohn's disease	0.00013	0.0404	CrCbGaD
Clomipramine—Amitriptyline—ALB—Crohn's disease	0.000128	0.0399	CrCbGaD
Clomipramine—HTR2B—Signaling by GPCR—IL3—Crohn's disease	4.77e-05	0.000656	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—PTGER4—Crohn's disease	4.72e-05	0.00065	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	4.68e-05	0.000644	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—RASGRP1—Crohn's disease	4.61e-05	0.000635	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—RSPO3—Crohn's disease	4.58e-05	0.000631	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CCR9—Crohn's disease	4.57e-05	0.00063	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—PTGER4—Crohn's disease	4.51e-05	0.000622	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PLA2G4F—Crohn's disease	4.5e-05	0.000619	CbGpPWpGaD
Clomipramine—HTR2A—SIDS Susceptibility Pathways—TNF—Crohn's disease	4.46e-05	0.000614	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—CCR6—Crohn's disease	4.46e-05	0.000614	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.46e-05	0.000614	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—CCR6—Crohn's disease	4.45e-05	0.000613	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	4.38e-05	0.000603	CbGpPWpGaD
Clomipramine—HTR6—GPCR ligand binding—CXCL8—Crohn's disease	4.37e-05	0.000602	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—SEL1L—Crohn's disease	4.34e-05	0.000598	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—PTGER4—Crohn's disease	4.32e-05	0.000594	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—ITGA4—Crohn's disease	4.28e-05	0.00059	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—UBE2D1—Crohn's disease	4.25e-05	0.000586	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—GPR65—Crohn's disease	4.25e-05	0.000585	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—IL3—Crohn's disease	4.23e-05	0.000583	CbGpPWpGaD
Clomipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	4.23e-05	0.000582	CbGpPWpGaD
Clomipramine—ADRA2A—G alpha (i) signalling events—CXCL8—Crohn's disease	4.2e-05	0.000578	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—IL3—Crohn's disease	4.18e-05	0.000575	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—RSPO3—Crohn's disease	4.17e-05	0.000574	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—RIPK2—Crohn's disease	4.12e-05	0.000568	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CCR6—Crohn's disease	4.11e-05	0.000566	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—RASGRP1—Crohn's disease	4.1e-05	0.000564	CbGpPWpGaD
Clomipramine—ALB—Selenium Micronutrient Network—IL6—Crohn's disease	4.09e-05	0.000563	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—CCR6—Crohn's disease	4.05e-05	0.000558	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—RASGRP1—Crohn's disease	4.04e-05	0.000556	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	4.04e-05	0.000556	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—IL2RA—Crohn's disease	4.03e-05	0.000555	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—IL3—Crohn's disease	4.02e-05	0.000554	CbGpPWpGaD
Clomipramine—HTR2B—GPCR ligand binding—CXCL8—Crohn's disease	3.99e-05	0.000549	CbGpPWpGaD
Clomipramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	3.98e-05	0.000547	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CCR9—Crohn's disease	3.97e-05	0.000547	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—SEL1L—Crohn's disease	3.95e-05	0.000544	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PLA2G4F—Crohn's disease	3.94e-05	0.000543	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—PTGER4—Crohn's disease	3.93e-05	0.000541	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—PTGER4—Crohn's disease	3.92e-05	0.00054	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—RASGRP1—Crohn's disease	3.89e-05	0.000536	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—IL3—Crohn's disease	3.84e-05	0.000529	CbGpPWpGaD
Clomipramine—ALB—Metabolism—MTMR3—Crohn's disease	3.83e-05	0.000527	CbGpPWpGaD
Clomipramine—ALB—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	3.82e-05	0.000525	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—FADS1—Crohn's disease	3.78e-05	0.00052	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CCR6—Crohn's disease	3.75e-05	0.000517	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—RBX1—Crohn's disease	3.72e-05	0.000512	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—RASGRP1—Crohn's disease	3.72e-05	0.000512	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	3.71e-05	0.000511	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—IL2RA—Crohn's disease	3.71e-05	0.000511	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—GPR65—Crohn's disease	3.69e-05	0.000508	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—IL3—Crohn's disease	3.68e-05	0.000506	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—IL2RA—Crohn's disease	3.68e-05	0.000506	CbGpPWpGaD
Clomipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	3.67e-05	0.000506	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—IL2RA—Crohn's disease	3.66e-05	0.000504	CbGpPWpGaD
Clomipramine—SLC6A2—Transmembrane transport of small molecules—ALB—Crohn's disease	3.64e-05	0.000502	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—PTGER4—Crohn's disease	3.62e-05	0.000499	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CCR9—Crohn's disease	3.61e-05	0.000497	CbGpPWpGaD
Clomipramine—HTR2A—SIDS Susceptibility Pathways—IL6—Crohn's disease	3.6e-05	0.000496	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—PTGER4—Crohn's disease	3.57e-05	0.000491	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—RASGRP1—Crohn's disease	3.56e-05	0.00049	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—GPX4—Crohn's disease	3.54e-05	0.000487	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	3.54e-05	0.000487	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—JAK2—Crohn's disease	3.53e-05	0.000486	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—SOCS1—Crohn's disease	3.52e-05	0.000485	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—MTMR3—Crohn's disease	3.43e-05	0.000473	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—GCKR—Crohn's disease	3.41e-05	0.00047	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—RBX1—Crohn's disease	3.4e-05	0.000467	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—TYK2—Crohn's disease	3.36e-05	0.000463	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—GPR65—Crohn's disease	3.36e-05	0.000462	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—MTMR3—Crohn's disease	3.35e-05	0.000461	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—IL3—Crohn's disease	3.34e-05	0.000461	CbGpPWpGaD
Clomipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	3.34e-05	0.00046	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—IL3—Crohn's disease	3.34e-05	0.00046	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—IL2RA—Crohn's disease	3.34e-05	0.00046	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—PTGER4—Crohn's disease	3.31e-05	0.000455	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—ALB—Crohn's disease	3.26e-05	0.000449	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—UBE2D1—Crohn's disease	3.26e-05	0.000449	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—RASGRP1—Crohn's disease	3.24e-05	0.000445	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—RASGRP1—Crohn's disease	3.23e-05	0.000445	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—CXCL8—Crohn's disease	3.22e-05	0.000444	CbGpPWpGaD
Clomipramine—HTR2C—GPCR ligand binding—CXCL8—Crohn's disease	3.22e-05	0.000443	CbGpPWpGaD
Clomipramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	3.21e-05	0.000442	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—JAK2—Crohn's disease	3.21e-05	0.000441	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—RIPK2—Crohn's disease	3.16e-05	0.000435	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—MTMR3—Crohn's disease	3.16e-05	0.000435	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	3.15e-05	0.000433	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IL3—Crohn's disease	3.08e-05	0.000425	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—SMAD3—Crohn's disease	3.04e-05	0.000419	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—IL3—Crohn's disease	3.04e-05	0.000418	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CCR6—Crohn's disease	3.03e-05	0.000417	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—RASGRP1—Crohn's disease	2.98e-05	0.000411	CbGpPWpGaD
Clomipramine—ALB—Metabolism—FADS1—Crohn's disease	2.98e-05	0.00041	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—UBE2D1—Crohn's disease	2.98e-05	0.00041	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—IL2RA—Crohn's disease	2.97e-05	0.000408	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—RASGRP1—Crohn's disease	2.94e-05	0.000405	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—IL2RA—Crohn's disease	2.93e-05	0.000403	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—CXCL8—Crohn's disease	2.93e-05	0.000403	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—RIPK2—Crohn's disease	2.89e-05	0.000398	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—PTGS2—Crohn's disease	2.85e-05	0.000393	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—IL2RA—Crohn's disease	2.82e-05	0.000388	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IL3—Crohn's disease	2.82e-05	0.000388	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—CXCL8—Crohn's disease	2.8e-05	0.000385	CbGpPWpGaD
Clomipramine—ALB—Metabolism—GPX4—Crohn's disease	2.79e-05	0.000384	CbGpPWpGaD
Clomipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	2.79e-05	0.000383	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—RBX1—Crohn's disease	2.74e-05	0.000377	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—RASGRP1—Crohn's disease	2.72e-05	0.000375	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—JAK2—Crohn's disease	2.71e-05	0.000373	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—SOCS1—Crohn's disease	2.7e-05	0.000372	CbGpPWpGaD
Clomipramine—ALB—Metabolism—GCKR—Crohn's disease	2.7e-05	0.000371	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—IL2RA—Crohn's disease	2.69e-05	0.000371	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—ALB—Crohn's disease	2.68e-05	0.000369	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—MTMR3—Crohn's disease	2.68e-05	0.000368	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—FADS1—Crohn's disease	2.68e-05	0.000368	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PTGER4—Crohn's disease	2.67e-05	0.000367	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CCR6—Crohn's disease	2.63e-05	0.000362	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—FADS1—Crohn's disease	2.61e-05	0.00036	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—TYK2—Crohn's disease	2.58e-05	0.000355	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—IL2RA—Crohn's disease	2.58e-05	0.000355	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—CXCL8—Crohn's disease	2.54e-05	0.00035	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GPX4—Crohn's disease	2.51e-05	0.000345	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—JAK2—Crohn's disease	2.49e-05	0.000343	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—JAK2—Crohn's disease	2.47e-05	0.00034	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—CXCL8—Crohn's disease	2.47e-05	0.00034	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—SOCS1—Crohn's disease	2.47e-05	0.00034	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—FADS1—Crohn's disease	2.46e-05	0.000339	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—JAK2—Crohn's disease	2.46e-05	0.000338	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GPX4—Crohn's disease	2.45e-05	0.000337	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	2.43e-05	0.000334	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GCKR—Crohn's disease	2.42e-05	0.000333	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—UBE2D1—Crohn's disease	2.4e-05	0.000331	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CCR6—Crohn's disease	2.39e-05	0.000329	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	2.39e-05	0.000329	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—RBX1—Crohn's disease	2.38e-05	0.000328	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GCKR—Crohn's disease	2.36e-05	0.000325	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—TYK2—Crohn's disease	2.35e-05	0.000324	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—IL2RA—Crohn's disease	2.34e-05	0.000323	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—IL2RA—Crohn's disease	2.34e-05	0.000322	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—SMAD3—Crohn's disease	2.33e-05	0.000321	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—RIPK2—Crohn's disease	2.33e-05	0.000321	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PTGER4—Crohn's disease	2.32e-05	0.000319	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GPX4—Crohn's disease	2.3e-05	0.000317	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IL3—Crohn's disease	2.27e-05	0.000313	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—CXCL8—Crohn's disease	2.26e-05	0.000311	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—JAK2—Crohn's disease	2.24e-05	0.000309	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—CXCL8—Crohn's disease	2.24e-05	0.000309	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GCKR—Crohn's disease	2.23e-05	0.000306	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—RASGRP1—Crohn's disease	2.2e-05	0.000302	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—RBX1—Crohn's disease	2.16e-05	0.000298	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IL2RA—Crohn's disease	2.16e-05	0.000297	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—SMAD3—Crohn's disease	2.13e-05	0.000293	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—IL2RA—Crohn's disease	2.13e-05	0.000293	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PTGER4—Crohn's disease	2.11e-05	0.00029	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—UBE2D1—Crohn's disease	2.09e-05	0.000287	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—FADS1—Crohn's disease	2.08e-05	0.000287	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—MTMR3—Crohn's disease	2.06e-05	0.000284	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—CXCL8—Crohn's disease	2.05e-05	0.000282	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—RIPK2—Crohn's disease	2.02e-05	0.000278	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—JAK2—Crohn's disease	1.99e-05	0.000274	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—SOCS1—Crohn's disease	1.99e-05	0.000274	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TYK2—Crohn's disease	1.98e-05	0.000273	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IL3—Crohn's disease	1.97e-05	0.000272	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IL2RA—Crohn's disease	1.97e-05	0.000272	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—JAK2—Crohn's disease	1.97e-05	0.000271	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GPX4—Crohn's disease	1.95e-05	0.000269	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—RASGRP1—Crohn's disease	1.91e-05	0.000263	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—TYK2—Crohn's disease	1.9e-05	0.000261	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—UBE2D1—Crohn's disease	1.9e-05	0.000261	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—JAK2—Crohn's disease	1.89e-05	0.000261	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GCKR—Crohn's disease	1.89e-05	0.00026	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—RIPK2—Crohn's disease	1.84e-05	0.000253	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—CXCL8—Crohn's disease	1.82e-05	0.000251	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—JAK2—Crohn's disease	1.81e-05	0.000249	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL3—Crohn's disease	1.79e-05	0.000247	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—RASGRP1—Crohn's disease	1.74e-05	0.000239	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—JAK2—Crohn's disease	1.73e-05	0.000238	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.73e-05	0.000238	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—SOCS1—Crohn's disease	1.73e-05	0.000238	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—CXCL8—Crohn's disease	1.73e-05	0.000238	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—SMAD3—Crohn's disease	1.72e-05	0.000237	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.68e-05	0.000232	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—CXCL8—Crohn's disease	1.65e-05	0.000227	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—TYK2—Crohn's disease	1.65e-05	0.000227	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—IL6—Crohn's disease	1.64e-05	0.000226	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—FADS1—Crohn's disease	1.61e-05	0.000222	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.6e-05	0.000221	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IL2RA—Crohn's disease	1.59e-05	0.000219	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—CXCL8—Crohn's disease	1.58e-05	0.000218	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—JAK2—Crohn's disease	1.57e-05	0.000217	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—SOCS1—Crohn's disease	1.57e-05	0.000217	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—JAK2—Crohn's disease	1.57e-05	0.000216	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TYK2—Crohn's disease	1.52e-05	0.00021	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.51e-05	0.000208	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GPX4—Crohn's disease	1.51e-05	0.000207	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—TYK2—Crohn's disease	1.5e-05	0.000206	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—SMAD3—Crohn's disease	1.49e-05	0.000205	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GCKR—Crohn's disease	1.45e-05	0.0002	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—JAK2—Crohn's disease	1.45e-05	0.0002	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—CXCL8—Crohn's disease	1.44e-05	0.000198	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—CXCL8—Crohn's disease	1.43e-05	0.000198	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—JAK2—Crohn's disease	1.43e-05	0.000197	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—STAT3—Crohn's disease	1.39e-05	0.000191	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TYK2—Crohn's disease	1.39e-05	0.000191	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IL2RA—Crohn's disease	1.38e-05	0.00019	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—SMAD3—Crohn's disease	1.36e-05	0.000187	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.35e-05	0.000185	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—JAK2—Crohn's disease	1.33e-05	0.000183	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CXCL8—Crohn's disease	1.33e-05	0.000182	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—CXCL8—Crohn's disease	1.31e-05	0.00018	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—IL6—Crohn's disease	1.26e-05	0.000174	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL2RA—Crohn's disease	1.26e-05	0.000173	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CXCL8—Crohn's disease	1.21e-05	0.000167	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.18e-05	0.000162	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—IL6—Crohn's disease	1.15e-05	0.000158	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TYK2—Crohn's disease	1.12e-05	0.000154	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—ALB—Crohn's disease	1.09e-05	0.00015	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—JAK2—Crohn's disease	1.07e-05	0.000147	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—STAT3—Crohn's disease	1.07e-05	0.000147	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CXCL8—Crohn's disease	9.76e-06	0.000134	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TYK2—Crohn's disease	9.73e-06	0.000134	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—STAT3—Crohn's disease	9.73e-06	0.000134	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—IL6—Crohn's disease	9.71e-06	0.000134	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PTGS2—Crohn's disease	9.51e-06	0.000131	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—JAK2—Crohn's disease	9.29e-06	0.000128	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—IL6—Crohn's disease	9.28e-06	0.000128	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TYK2—Crohn's disease	8.86e-06	0.000122	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CXCL8—Crohn's disease	8.48e-06	0.000117	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—JAK2—Crohn's disease	8.45e-06	0.000116	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—IL6—Crohn's disease	8.06e-06	0.000111	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—STAT3—Crohn's disease	7.85e-06	0.000108	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CXCL8—Crohn's disease	7.71e-06	0.000106	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ALB—Crohn's disease	7.7e-06	0.000106	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—ALB—Crohn's disease	7.52e-06	0.000103	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PTGS2—Crohn's disease	7.5e-06	0.000103	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IL6—Crohn's disease	7.45e-06	0.000103	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—IL6—Crohn's disease	7.33e-06	0.000101	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ALB—Crohn's disease	7.08e-06	9.75e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—STAT3—Crohn's disease	6.82e-06	9.39e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IL6—Crohn's disease	6.8e-06	9.36e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PTGS2—Crohn's disease	6.74e-06	9.28e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PTGS2—Crohn's disease	6.58e-06	9.05e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—STAT3—Crohn's disease	6.2e-06	8.54e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PTGS2—Crohn's disease	6.2e-06	8.53e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ALB—Crohn's disease	6e-06	8.26e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IL6—Crohn's disease	5.48e-06	7.55e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PTGS2—Crohn's disease	5.25e-06	7.23e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IL6—Crohn's disease	4.76e-06	6.56e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ALB—Crohn's disease	4.63e-06	6.38e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL6—Crohn's disease	4.33e-06	5.96e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PTGS2—Crohn's disease	4.05e-06	5.58e-05	CbGpPWpGaD
